Biomarkers to determine an early erosive process in RA

​The UPEDRA study (Prediction of erosive disease in early RA by ultrasound and cartilage biodegradation markers) is a collaboration between the Universities of Zurich and Basel. Newly diagnosed RA-patients are examined clinically as well as with x-ray, ultrasound and MRI at the beginning and during the progress of their treatment. This study takes place in close collaboration with the Clinical Trials Center RUZ.

We use cookies to make our website user-friendly, to continuously improve it and to analyze the traffic of our website. By continuing to browse the site, you are agreeing to our use of cookies. Further information can be found in our privacy policy.